← Leaderboards
Ravindra Uppaluri
Washington University
$8,689,991
Attributed
$13,400,801
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,400,801 · 5
By mechanism
R01$8,533,333 · 3
U01$4,259,203 · 1
K08$608,265 · 1
Top collaborators
- David A Barbie1 shared
- Robert I. Haddad1 shared
- Scott J Rodig1 shared
Most similar at Washington University
Same institution · by research overlap
- William E Gillanders$14,751,159
- Robert David Schreiber$32,299,425
- William G Hawkins$8,815,633
- David G Denardo$14,438,310
- Kristen Marie Sanfilippo$1,668,381
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsSpecimenClinical TrialsMalignant NeoplasmsCell LineResistanceTumorMouse ModelBiologyMutationSamplingInsightBaseTranslatingTherapeutic TargetIn VivoMouth Squamous Cell CarcinomaGenomicsTranscriptomicsTransplantationRecurrenceCancer CellNational Institute Of Dental And Craniofacial ResearchPattern
Grant awards (17)
Dissecting CCL5 contribution to antigen specific T cell responses in head and neck cancers$3,742,682
R01 · FY2025 · DE · contact PI
Immunotherapeutic responses to neoantigens in head and neck cancer$572,257
R01 · FY2022 · DE · contact PI
Immunotherapeutic responses to neoantigens in head and neck cancer$578,036
R01 · FY2021 · DE · contact PI
Immunotherapeutic responses to neoantigens in head and neck cancer$578,036
R01 · FY2020 · DE · contact PI
Defining mechanisms of immunotherapy resistance in head and neck squamous cell carcinomas$4,259,203
U01 · FY2019 · DE · contact PI
Immunotherapeutic responses to neoantigens in head and neck cancer$578,036
R01 · FY2019 · DE · contact PI
Immunotherapeutic responses to neoantigens in head and neck cancer$578,036
R01 · FY2018 · DE · contact PI
GENOMIC INSIGHTS AND THERAPEUTIC TARGETING OF ORAL CANCER TUMOR INITIATING CELLS$381,250
R01 · FY2018 · DE · contact PI
GENOMIC INSIGHTS AND THERAPEUTIC TARGETING OF ORAL CANCER TUMOR INITIATING CELLS$381,250
R01 · FY2017 · DE · contact PI
GENOMIC INSIGHTS AND THERAPEUTIC TARGETING OF ORAL CANCER TUMOR INITIATING CELLS$381,250
R01 · FY2016 · DE · contact PI
GENOMIC INSIGHTS AND THERAPEUTIC TARGETING OF ORAL CANCER TUMOR INITIATING CELLS$381,250
R01 · FY2015 · DE · contact PI
GENOMIC INSIGHTS AND THERAPEUTIC TARGETING OF ORAL CANCER TUMOR INITIATING CELLS$381,250
R01 · FY2014 · DE · contact PI
IFN Gamma Induced Angiostatic Chemokines$121,653
K08 · FY2006 · CA · contact PI
IFN Gamma Induced Angiostatic Chemokines$121,653
K08 · FY2005 · CA
IFN Gamma Induced Angiostatic Chemokines$121,653
K08 · FY2004 · CA
IFN Gamma Induced Angiostatic Chemokines$121,653
K08 · FY2003 · CA
IFN Gamma Induced Angiostatic Chemokines$121,653
K08 · FY2002 · CA